Design and Synthesis of Fluorescent Betahistine Conjugates with Unique Imaging Property

Article Preview

Abstract:

Labeling cardiovascular drugs probes with a fluorescent tag is an alternative method of measuring drugs activities and distributions in vivo, and further using of advanced tools to diagnose or detect cardiovascular diseases. Using this approach, a fluorescent probe (betahistine-Flu, 1) of Betahistine-based was synthesized and characterized by 1H NMR, 13C NMR and LC-MS, and its UV-Vis absorption spectral and fluorescence spectral, and fluorescence imaging in cell model were investigated. It was found that the fluorescent probe display strong green fluorescence, and have good optical effect in cell. This study reveals a good and interesting results of betahistine-directed fluorescent probe, and its may be a possible candidate for cardiovascular disease diagnosis and analysis in vivo.

You might also be interested in these eBooks

Info:

Periodical:

Advanced Materials Research (Volumes 557-559)

Pages:

712-715

Citation:

Online since:

July 2012

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2012 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] Y. Zhou, J.Y. Yoon. Chem. Soc. Rev. 2012, 41, 52-67.

Google Scholar

[2] S. S. Kelkar, T. M. Reineke. Bioconjugate Chem. 2011, 22, 1879-1903.

Google Scholar

[3] R. Weissleder, M. J. Pittet. Nature 2008, 452, 580-589.

Google Scholar

[4] K. Miki, K. Oride, S. Inoue, Y. Kura mochi, RR. Navak, H. Matsuoka, H. Harada, M. Hiraoka, K. Ohe. Biomaterials 2010, 31, 934-942.

DOI: 10.1016/j.biomaterials.2009.10.005

Google Scholar

[5] B. Franz, A. D. Shafton, C. R. Anderson. Acta Oto-Laryngologica 2011, 131, 1155-1159.

DOI: 10.3109/00016489.2011.607847

Google Scholar

[6] A. B. Smith, P. V. Rucker, I. Brouard et al. Org. Lett. 2005, 7, 5199-5202.

Google Scholar